Thomas W. Beetham, EVP & Chief Legal Officer at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 97,364 shares at $19.06 ($1.9M) on 2020-04-20, disclosed to the SEC on 2020-04-22.
Open-market sale of $1.9M KNSA by EVP & Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.06 | 47,423 | $904K | 48.7% |
| 2 | $19.06 | 47,423 | $904K | 48.7% |
| 3 | $19.56 | 1,563 | $31K | 1.6% |
| 4 | $20.44 | 955 | $20K | 1.1% |
| Total | $19.08 avg | 97,364 | $1.9M | 100% |
| Filing → |
| KNSA | SELL | 2021-02-05 | $109K | — | Filing → |
| KNSA | SELL | 2020-07-02 | $1.5M | — | Filing → |
| KNSA | SELL | 2020-06-12 | $690K | — | Filing → |